Press release
Pelvic Inflammatory Disease Market Size And Global Industry Forecast 2034
Pelvic Inflammatory Disease Market
The pelvic inflammatory disease (PID) market is a significant component of women's reproductive healthcare, addressing a condition that can have severe consequences if left untreated-including chronic pelvic pain, infertility, and ectopic pregnancy. PID is most often caused by untreated sexually transmitted infections (STIs) such as chlamydia and gonorrhea, and its management involves prompt diagnosis and targeted antimicrobial therapy.
Growing global focus on sexual health education, STI prevention, and early intervention is driving steady market expansion.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/70737
Market Overview
• Market size (2024): USD 1.35 billion
• Forecast (2034): USD 2.12 billion
• CAGR (2025-2034): ~4.6%
Key Drivers:
• Rising prevalence of STIs globally.
• Improved screening programs and awareness campaigns.
• Growing demand for effective antibiotic regimens and supportive care solutions.
Key Challenges:
• Underdiagnosis due to asymptomatic cases.
• Antibiotic resistance affecting treatment efficacy.
• Stigma surrounding sexual health discussions in certain cultures.
Segmentation Analysis
• Treatment Type:
o Antibiotics (broad-spectrum and combination therapies)
o Surgical interventions (for severe or recurrent cases)
o Supportive care (pain management, hospitalization when needed)
• Pathogen:
o Chlamydia trachomatis
o Neisseria gonorrhoeae
o Polymicrobial infections
• End User:
o Hospitals
o Sexual health clinics
o Ambulatory care centers
• Geography:
o North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Summary: The market is dominated by antibiotic treatments but is increasingly incorporating preventive strategies and patient education initiatives.
Get Your Exclusive Offer with up to 10% Discount:
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=70737
Regional Analysis
• North America: Strong market share driven by comprehensive STI testing, established healthcare infrastructure, and insurance coverage.
• Europe: Consistent growth due to public health programs and broad access to diagnostics.
• Asia-Pacific: Fastest-growing region, supported by rising STI awareness, better access to care, and urban healthcare expansion.
• Latin America: Moderate growth, with opportunities in improving rural healthcare outreach.
• Middle East & Africa: Gradual market expansion, hindered by limited healthcare resources in some areas.
Regional Trend Summary: Developed markets lead in terms of diagnosis and treatment rates, but emerging regions offer significant growth potential through awareness and accessibility improvements.
Market Dynamics
Key Growth Drivers
• Public health campaigns focusing on STI prevention.
• Expansion of rapid diagnostic tests for early detection.
• Increasing inclusion of sexual health services in primary care.
Key Challenges
• Social stigma limiting testing and treatment uptake.
• Rising antibiotic resistance complicating treatment protocols.
• Limited access to specialized healthcare in rural areas.
Latest Trends
• Development of point-of-care diagnostics for faster PID detection.
• Integration of telehealth for STI consultations and treatment follow-up.
• Greater focus on partner treatment to reduce reinfection rates.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/70737/pelvic-inflammatory-disease-market
Competitor Analysis
Leading companies in the pelvic inflammatory disease market include:
• Pfizer Inc.
• GlaxoSmithKline plc
• Bayer AG
• Johnson & Johnson
• Teva Pharmaceutical Industries Ltd.
• Lupin Pharmaceuticals, Inc.
• Cipla Ltd.
• Mylan N.V.
These players focus on producing effective antibiotic regimens, expanding generic options, and collaborating with public health organizations for awareness and outreach.
Conclusion
The pelvic inflammatory disease market is projected to grow from USD 1.35 billion in 2024 to USD 2.12 billion by 2034, at a CAGR of around 4.6%. This growth is driven by rising STI prevalence, public health awareness, and advancements in diagnostics and treatment protocols.
This report is also available in the following languages : Japanese (骨盤内炎症性疾患市場), Korean (골반 염증성 질환 시장), Chinese (盆腔炎市场), French (Marché des maladies inflammatoires pelviennes), German (Markt für entzündliche Erkrankungen des Beckens), and Italian (Mercato della malattia infiammatoria pelvica), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/70737
Our More Report:
Fully Electric Aircraft Tugs Market
https://exactitudeconsultancy.com/request-sample/65005
Superconducting MRI System Market
https://exactitudeconsultancy.com/request-sample/65003
Heating Jackets Market
https://exactitudeconsultancy.com/request-sample/65001
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pelvic Inflammatory Disease Market Size And Global Industry Forecast 2034 here
News-ID: 4140179 • Views: …
More Releases from Exactitiude Consultancy
Non-Muscle Invasive Bladder Cancer Market Industry Analysis by Size, Share, Grow …
Introduction
The Non-Muscle Invasive Bladder Cancer (NMIBC) market is poised for significant growth as advancements in intravesical therapies, immuno-oncology drugs, and molecular diagnostics improve patient outcomes. NMIBC, which accounts for about 70-75% of all newly diagnosed bladder cancer cases, is characterized by high recurrence rates but relatively low mortality compared to muscle-invasive forms. The rising global prevalence, particularly among aging populations, is prompting greater investment in early diagnosis, novel drug delivery…
NK Cell Therapy Market Size And Global Industry Forecast 2034
NK Cell Therapy Market Outlook 2024-2034: Immuno-Oncology Innovation and Off-the-Shelf Therapies Set the Stage for Rapid Growth
Introduction
The Natural Killer (NK) Cell Therapy market is one of the most dynamic segments in immuno-oncology, driven by breakthroughs in cell engineering, off-the-shelf allogeneic therapies, and combination regimens with checkpoint inhibitors. NK cells, part of the innate immune system, have demonstrated strong potential in targeting and destroying cancer cells without prior sensitization, making them…
Neuroendocrine Prostate Cancer Market Size, Share and Growth Report, 2034
Introduction
The Neuroendocrine Prostate Cancer (NEPC) market is emerging as a key focus area in oncology due to its aggressive nature, poor prognosis, and increasing recognition as a distinct clinical entity. NEPC can develop de novo or as a treatment-emergent form of advanced prostate cancer following androgen deprivation therapy (ADT) resistance. While rare, NEPC is challenging to treat, requiring a combination of chemotherapy, targeted agents, and investigational therapies. Rising awareness, advancements…
Metastatic Colorectal Cancer Market Size And Global Industry Forecast 2034
Introduction
The Metastatic Colorectal Cancer (mCRC) market is entering a transformative phase as precision medicine, biomarker-driven treatment strategies, and immunotherapy reshape patient care. Increasing adoption of EGFR inhibitors, VEGF inhibitors, immune checkpoint inhibitors, and combination regimens is improving survival rates, while advancements in molecular diagnostics are enabling more tailored treatment approaches. Over the next decade, continuous R&D efforts and expanded access to innovative therapies are expected to drive market growth.
Download Full…
More Releases for STI
Solar PV Tracker Market Future Business Opportunities 2025-2032 | PVHardware, ST …
Solar PV Tracker Market Analysis - 2025-2032:
Coherent Market Insights has released a new report titled "Solar PV Tracker Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032 (Version 2025)." This report provides an in-depth analysis of the Solar PV Tracker industry, featuring insights on market trends and performance. It also includes a thorough examination of competitors, regional dynamics, and the latest advancements within the market.
Coverage of the Solar PV…
Global CMP Slurry for ILD and STI Market Research Report 2024-2030
Global Leading Market Research Publisher QYResearch announces the release of its lastest report "Global CMP Slurry for ILD and STI Market Report, History and Forecast 2019-2030, Breakdown Data by Manufacturers, Key Regions, Types and Application". Based on historical analysis (2019-2023) and forecast calculations (2024-2030), this report provides a comprehensive analysis of the global CMP Slurry for ILD and STI market, including market size, share, demand, industry development status, and forecasts…
Global Superconducting Cables Market 2017 - MetOx, STI, Bruker, Oxford Instrumen …
The worldwide Superconducting Cables Market report is an in-depth research on the current situation of the Superconducting Cables industry. The research study of Global Superconducting Cables Market 2017 offers a strategic assessment of Superconducting Cables market. The industry report focuses on the growth opportunities, which will help the Superconducting Cables industry to expand operations in the existing markets globally.
Firstly, Superconducting Cables Market report introduces a basic overview of the Superconducting…
High Temperature Superconductor Market 2016 - AMSC, SuperPower, MetOx, STI, Bruk …
The Global High Temperature Superconductor Market 2016 Industry Research Report focused on major manufacturers, regions, type as well as application of the High Temperature Superconductor industry. High temperature superconductors are materials that behave as superconductors at unusually high temperatures. The high temperature superconductors represent a new class of materials that bear extraordinary superconducting, magnetic properties and great potential for various technological applications.
Scope of the Report:
This report focuses on the High…
Bullrun Veteran Subaru STI Updated by Vivid Racing
This Subaru STI Sedan got to thrash across the USA on the 2011 Bullrun rally. However, after running the car hard, it was time for some updates. Already equipped with a slew of Agency Power parts, it was time to enhance the engine. Getting new forged internals with JE pistons, the 2.5L block is now ready to take some boost from the Agency Power GT30 rotated mount…
Cosworth Subaru STI is New Project Car for Vivid Racing
A fully built Cosworth Subaru STI has just become Vivid Racing's new project car. Having started out modifying Subaru's in 2001, VR has created some very well rounded WRX's and STI's.
Their 2007 pearl white STI project car was featured in both the October 2007 issue of Top Performance from Dubai and the December 2007 issue of Performance Auto and Sound. It attracted the automotive car world with its Agency Power…
